ArticleMedicine2025
Treatment targets of cellular senescence and circadian rhythms in ischemic stroke.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ischemic stroke poses a substantial public health burden due to its high incidence, rendering it an urgent medical concern. Emerging evidence suggests that cellular senescence and circadian rhythms are closely linked to the onset of cerebral infarction and may represent promising therapeutic targets. Accordingly, we retrieved datasets GSE16561 and GSE22255 from the Gene Expression Omnibus and extracted cellular senescence- and circadian rhythm-related genes from the GeneCards database. Through bioinformatics analysis, we identified key targets associated with cellular senescence and circadian rhythm in cerebral infarction, specifically CREBBP, FOS, CDK4, MMP9, PTEN, and HIF1A. Complementing these findings with in vitro experiments, our results demonstrate that the expression of these genes and proteins at these core targets are elevated to varying degrees in an in vitro model of cerebral infarction. These findings provide compelling evidence supporting the pivotal role of cellular senescence- and circadian rhythm-related genes in the pathogenesis of ischemic stroke.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.